Lv2
110 积分 2024-12-20 加入
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
1个月前
已完结
Real-world evidence supports earlier treatment in HBeAg-positive but not HBeAg-negative chronic hepatitis B virus infection
5个月前
已完结
Real-world evidence supports earlier treatment in HBeAg-positive but not HBeAg-negative chronic hepatitis B virus infection
5个月前
已关闭
Safety considerations for finite nucleos(t)ide analogue (NA) in Chronic Hepatitis B infection, a single-center, observational and restrospective study
5个月前
已关闭
Safety considerations for finite nucleos(t)ide analogue (NA) in Chronic Hepatitis B infection, a single-center, observational and restrospective study
5个月前
已关闭
Safety considerations for finite nucleos(t)ide analogue (NA) in Chronic Hepatitis B infection, a single-center, observational and restrospective study
5个月前
已关闭
Viscosity Plane-Wave Ultrasound Combined With Serum Biomarkers for Detection of Significant Liver Inflammation: A Diagnostic Nomogram Study
5个月前
已关闭
Scientific and medical evidence informing expansion of hepatitis B treatment guidelines
5个月前
已完结
Cost‐Effectiveness of Antiviral Therapy in Patients With High Viremic Indeterminate Phase Chronic Hepatitis B
5个月前
已完结
Hepatitis B core-related antigen kinetics predict spontaneous HBeAg seroclearance in chronic hepatitis B patients
5个月前
已完结
皖公网安备34019202002308
